Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Letizia, Gnetti"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/9cfbfaa6588c4ff1a2d117574915d856
Autor:
Melissa Bersanelli, Letizia Gnetti, Francesco Paolo Pilato, Elena Varotti, Federico Quaini, Nicoletta Campanini, Elena Rapacchi, Roberta Camisa, Paolo Carbognani, Enrico Maria Silini, Michele Rusca, Francesco Leonardi, Umberto Maestroni, Mimma Rizzo, Matteo Brunelli, Sebastiano Buti, Luca Ampollini
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 4, Pp 743-756 (2023)
Aim: In renal cell carcinoma (RCC), tumor heterogeneity generated challenges to biomarker development and therapeutic management, often becoming responsible for primary and acquired drug resistance. This study aimed to assess the inter-tumoral, intra
Externí odkaz:
https://doaj.org/article/e9629c4493ad4954bcecdc2c4c5fa8ce
Autor:
Francesca Negri, Lorena Bottarelli, Giuseppe Pedrazzi, Michele Maddalo, Ludovica Leo, Gianluca Milanese, Roberto Sala, Michele Lecchini, Nicoletta Campanini, Cecilia Bozzetti, Andrea Zavani, Gianluca Di Rienzo, Cinzia Azzoni, Enrico Maria Silini, Nicola Sverzellati, Federica Gaiani, Gian Luigi de’ Angelis, Letizia Gnetti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionThe Notch intracellular domain (NICD) and its ligands Jagged-1(Jag1), Delta-like ligand (DLL-3) and DLL4 play an important role in neoangiogenesis. Previous studies suggest a correlation between the tissue levels of NICD and response to t
Externí odkaz:
https://doaj.org/article/7b444c4b7221495b890416abc0bc4077
Publikováno v:
International Journal of Medical Toxicology and Forensic Medicine, Vol 13, Iss 3 (2023)
Tadalafil is an inhibitor of the enzyme human cyclic guanosine monophosphate–specific phosphodiesterase, type 5 (PDE-5). A mild vasodilator, it is primarily used for the treatment of erectile dysfunction (ED), an increasingly common condition. Othe
Externí odkaz:
https://doaj.org/article/11f8b3097c204c82ba860c38cf9b3b51
Publikováno v:
International Journal of Medical Toxicology and Forensic Medicine, Vol 13, Iss 3, Pp 40058-40058 (2023)
Tadalafil is an inhibitor of the enzyme human cyclic guanosine monophosphate–specific phosphodiesterase, type 5 (PDE-5). A mild vasodilator, it is primarily used for the treatment of erectile dysfunction (ED), an increasingly common condition. Othe
Externí odkaz:
https://doaj.org/article/aeaf04109184471aa0303aa1577d6b87
Autor:
Roberta Minari, PhD, Samuel Valentini, MSc, Denise Madeddu, PhD, Andrea Cavazzoni, PhD, Silvia La Monica, PhD, Costanza Anna Maria Lagrasta, MSc, Roberto Bertorelli, MSc, Veronica De Sanctis, PhD, Paola Fassan, MSc, Cinzia Azzoni, PhD, Lorena Bottarelli, PhD, Caterina Frati, PhD, Letizia Gnetti, MD, Francesco Facchinetti, MD, Pier Giorgio Petronini, PhD, Roberta Alfieri, PhD, Alessandro Romanel, PhD, Marcello Tiseo, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 2, Pp 100278- (2022)
Introduction: ALK tyrosine kinase inhibitors (TKIs) are the standard treatment for advanced ALK-positive NSCLC. Nevertheless, drug resistance inevitably occurs. Here, we report a case of a patient with metastatic ALK-positive lung adenocarcinoma with
Externí odkaz:
https://doaj.org/article/e7a0f0aaa4584907a17791252608959c
Autor:
Giovanni Maria Rossi, Marco Delsante, Francesco Paolo Pilato, Letizia Gnetti, Liliana Gabrielli, Giada Rossini, Maria Carla Re, Giovanna Cenacchi, Paola Affanni, Maria Eugenia Colucci, Edoardo Picetti, Sandra Rossi, Elisabetta Parenti, Caterina Maccari, Paolo Greco, Francesca Di Mario, Umberto Maggiore, Giuseppe Regolisti, Enrico Fiaccadori
Publikováno v:
Kidney International Reports, Vol 5, Iss 7, Pp 1100-1105 (2020)
Externí odkaz:
https://doaj.org/article/42a57c45985a4c9493b49297bcd4c01c
Autor:
Alessandra Anna Manco, Veronica Alfieri, Letizia Gnetti, Marina Aiello, Giuseppina Bertorelli, Maria Majori, Alfredo Chetta
Publikováno v:
European Journal of Case Reports in Internal Medicine (2021)
We report the case of a 46-year-old male patient who was referred for chest pain and bilateral pleural effusion. Despite treatment with antibiotics and steroids, the pleural effusion worsened over a few months until pulmonary function was halved. The
Externí odkaz:
https://doaj.org/article/86433927bc7345fca863a3a5ab16c1e0
Autor:
Alessandro Leonetti, Roberta Minari, Giulia Mazzaschi, Letizia Gnetti, Silvia La Monica, Roberta Alfieri, Nicoletta Campanini, Michela Verzè, Andrea Olivani, Luigi Ventura, Marcello Tiseo
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Introduction: Small cell lung cancer (SCLC) transformation represents a mechanism of resistance to osimertinib in EGFR-mutated lung adenocarcinoma, which dramatically impacts patients' prognosis due to high refractoriness to conventional treatments.C
Externí odkaz:
https://doaj.org/article/b1f8f75a6ce348e197abf27fa2247afe
Autor:
Fabiana Perrone, Giulia Mazzaschi, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Rita Nizzoli, Monica Pluchino, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Federica Bertolini, Fausto Barbieri, Stefania Bettelli, Lucia Longo, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Cancers, Vol 14, Iss 8, p 2019 (2022)
Introduction: BRAF mutation involved 2–4% of lung adenocarcinoma. Differences in clinicopathologic features and patient outcome exist between V600E and non-V600E BRAF mutated NSCLC. Thus, we sought to assess the frequency and clinical relevance of
Externí odkaz:
https://doaj.org/article/24526de529bb4f77aa24fda215647c5e